Dong P - Search Results

1

A review on the role of cyclin dependent kinases in cancers.

Ghafouri-Fard S, Khoshbakht T, Hussen BM, Dong P, Gassler N, Taheri M, Baniahmad A, Dilmaghani NA. Ghafouri-Fard S, et al. Among authors: dong p. Cancer Cell Int. 2022 Oct 20;22(1):325. doi: 10.1186/s12935-022-02747-z. Cancer Cell Int. 2022. PMID: 36266723 Free PMC article. Review.

2

LncRNAs: Novel Biomarkers for Pancreatic Cancer.

Ghafouri-Fard S, Fathi M, Zhai T, Taheri M, Dong P. Ghafouri-Fard S, et al. Among authors: dong p. Biomolecules. 2021 Nov 10;11(11):1665. doi: 10.3390/biom11111665. Biomolecules. 2021. PMID: 34827663 Free PMC article. Review.

3

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143.

Dong P, Wang F, Taheri M, Xiong Y, Ihira K, Kobayashi N, Konno Y, Yue J, Watari H. Dong P, et al. Front Oncol. 2022 May 27;12:912935. doi: 10.3389/fonc.2022.912935. eCollection 2022. Front Oncol. 2022. PMID: 35712514 Free PMC article.

4

The significance of N6-methyladenosine-modified non-coding RNAs in different disorders.

Ghafouri-Fard S, Shoorei H, Hussen BM, Dong P, Zhai T, Taheri M, Samadian M. Ghafouri-Fard S, et al. Among authors: dong p. Eur J Pharmacol. 2023 May 5;946:175644. doi: 10.1016/j.ejphar.2023.175644. Epub 2023 Mar 14. Eur J Pharmacol. 2023. PMID: 36921707 Review.

5

Editorial: Interplay between RNA-binding proteins and non-coding RNAs in tumor therapeutic resistance.

Dong P, Taheri M, Wang F. Dong P, et al. Front Oncol. 2023 Apr 20;13:1201122. doi: 10.3389/fonc.2023.1201122. eCollection 2023. Front Oncol. 2023. PMID: 37152004 Free PMC article. No abstract available.

6

Emerging functions and clinical applications of exosomal microRNAs in diseases.

Ghafouri-Fard S, Shoorei H, Dong P, Poornajaf Y, Hussen BM, Taheri M, Akbari Dilmaghani N. Ghafouri-Fard S, et al. Among authors: dong p. Noncoding RNA Res. 2023 May 9;8(3):350-362. doi: 10.1016/j.ncrna.2023.05.004. eCollection 2023 Sep. Noncoding RNA Res. 2023. PMID: 37250456 Free PMC article. Review.

7

New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets.

Hussen BM, Abdullah KH, Abdullah SR, Majeed NM, Mohamadtahr S, Rasul MF, Dong P, Taheri M, Samsami M. Hussen BM, et al. Among authors: dong p. Noncoding RNA Res. 2023 Sep 28;8(4):645-660. doi: 10.1016/j.ncrna.2023.09.003. eCollection 2023 Dec. Noncoding RNA Res. 2023. PMID: 37818447 Free PMC article.

8

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1.

Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, Sakuragi N. Dong P, et al. Mol Cancer. 2011 Aug 18;10:99. doi: 10.1186/1476-4598-10-99. Mol Cancer. 2011. PMID: 21851624 Free PMC article.

9

Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells.

Ji L, Zhao G, Zhang P, Huo W, Dong P, Watari H, Jia L, Pfeffer LM, Yue J, Zheng J. Ji L, et al. Among authors: dong p. J Cancer. 2018 Nov 11;9(24):4578-4585. doi: 10.7150/jca.28040. eCollection 2018. J Cancer. 2018. PMID: 30588241 Free PMC article.

10

A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways.

Wang B, Li H, Zhao X, Zhang W, Zhao G, Wu Z, Zhang R, Dong P, Watari H, Tigyi G, Li W, Yue J. Wang B, et al. Among authors: dong p. J Cancer. 2021 Jul 25;12(18):5654-5663. doi: 10.7150/jca.61066. eCollection 2021. J Cancer. 2021. PMID: 34405025 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,317 results

Search Page